Stay updated on DAPA-MI Trial: Dapagliflozin Post Heart Attack
Sign up to get notified when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.

Latest updates to the DAPA-MI Trial: Dapagliflozin Post Heart Attack page
- Check3 days agoChange DetectedThe history shows a new revision entry (v3.3.4) replacing the previous v3.3.3, with no changes to study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now displays a new footer revision notice 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' link and the previous 'Revision: v3.3.2' text were removed.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry (v3.3.2) was added to the page history, and the previous revision (v3.3.1) was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page shows a new Revision: v3.3.1 replacing v3.2.0, indicating a system/UI update. No study data, trial details, or core content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe government funding/status notice banner was removed from the page in the latest version, affecting only the UI banner and not the trial records or study details.SummaryDifference0.4%

- Check75 days agoChange DetectedNew screenshot shows minor UI/layout adjustments to the Record History page; the version list and primary content appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to DAPA-MI Trial: Dapagliflozin Post Heart Attack
Enter your email address, and we'll notify you when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.